Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.185    -0.005 (-2.63%)
Bid:
0.18
Ask:
0.19
Spread: 0.01 (5.556%)
Market Cap: £1.37m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Issue of Equity

5 Mar 2010 15:00

RNS Number : 1767I
ValiRx PLC
05 March 2010
 



ValiRx plc

 

(the "Company")

 

Issue of equity

 

The Company announces that it has issued 3,600,000 new ordinary shares in the Company ("Ordinary Shares") at 1p per share in lieu of fees owed. The admission of 3,600,000 new Ordinary Shares to trading on AIM is expected to occur on 11 March, 2010. On admission, the Company will have 157,945,030 Ordinary Shares in issue.

 

Enquiries:

 

ValiRx plc

Dr. Satu Vainikka

 

Tel: +44 (0) 20 3008 4416

 

WH Ireland Limited - Nominated Adviser & Broker

Adrian Kirk

 

Tel: +44 (0) 161 832 2174

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEZELFBBXFZBBV
Date   Source Headline
11th Aug 20177:00 amRNSConvertible Loan Facility
2nd Aug 20177:00 amRNSConversion of Loan Note
28th Jul 20177:00 amRNSLicencing Agreement
22nd Jun 20177:00 amRNSFormation of & Appointments to an Advisory Board
15th Jun 20177:00 amRNSValiSeek Development Update - Recruitment Closes
1st Jun 201711:00 amRNSYorkville CLN Conversion
31st May 201711:00 amRNSHardman Research:Developing novel cancer therapies
30th May 201710:34 amRNSResult of AGM
24th May 20177:00 amRNSNOTIFICATION OF AUSTRALIAN PATENT ALLOWANCE
5th May 20175:28 pmRNSNotice of AGM
5th May 20177:00 amRNSFinal Results
27th Apr 201710:07 amRNSRe: SHARES Magazine Supplement on ValiRx website
19th Apr 20179:00 amRNSChange of Registered Office
15th Mar 20179:33 amRNSDirector/PDMR Shareholding
8th Mar 20177:00 amRNSValiSeek Clinical Development Update
2nd Mar 20177:00 amRNSDirector/PDMR Shareholding
1st Mar 20171:37 pmRNSPlacing to raise £1.16m and Proposed Subscription
28th Feb 20177:00 amRNSPublication of Peer-Reviewed Articles on VAL401
11th Jan 20177:00 amRNSCLINICAL TRIAL UPDATE - Positive VAL201 Results
30th Dec 20167:00 amRNSYorkville CLN Conversion
8th Dec 20167:00 amRNSEuropean Patent Granted for Lead Compound VAL201
2nd Dec 20164:15 pmRNSConvertible Loan Facility
1st Dec 20167:00 amRNSValiSeek Clinical Development Update
29th Nov 20167:00 amRNSQuarterly Update on Clinical Developments
3rd Nov 20167:00 amRNSValiSeek Clinical Development Update
28th Oct 20169:00 amRNSCorporate Video re Clinical Status Q4, 2016
25th Oct 20167:00 amRNSPatent Update
13th Oct 20164:20 pmRNSHolding(s) in Company
13th Oct 20164:20 pmRNSHolding(s) in Company
13th Oct 20167:00 amRNSUpdate on Recent Presentations
12th Oct 201611:15 amRNSResult of General Meeting
5th Oct 20163:42 pmRNSCLN Conversion
28th Sep 201611:09 amRNSNotice of GM
27th Sep 20167:00 amRNSHalf-year Report
26th Sep 20167:00 amRNSValiRx selected for The Parliamentary Review 2016
13th Sep 20167:00 amRNSQuarterly Update on Clinical Developments
2nd Sep 20162:10 pmRNSPlacing, issue of warrants & Convertible Loan
11th Aug 20167:00 amRNSValiSeek Clinical Development Update
4th Aug 201611:32 amRNSIssue of Equity
28th Jul 20167:00 amRNSNotification of New Zealand Patent Grant Allowance
26th Jul 20167:00 amRNSIssue of Equity and Bracknor Facility Update
14th Jul 20167:00 amRNSValiSeek Clinical Development Update
12th Jul 201611:58 amRNSResult of GM
7th Jul 20167:00 amRNSSale of TRAC Technology Rights for EUR 0.8 million
27th Jun 20167:00 amRNSNotice of GM
20th Jun 20162:24 pmRNSResult of AGM
7th Jun 20167:00 amRNSQuarterly Update
7th Jun 20167:00 amRNSAppointment of Joint Broker
26th May 20168:00 amRNSPosting of Annual Report & Notice of AGM
19th May 201611:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.